Delivery Order SPE2DB20D2104-SPE2DB22FS07Q
Award Date
3/14/22
Potential Completion Date
3/15/22
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,252,687 units of Naloxone HCL 4 mg nasal spray. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $46,516.61, and an ultimate completion date of September 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB20D3103|SPE2DB23FN0Y8, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,452.65, is for the delivery of 4,560,615,921 units of Naloxone HCl 4 mg Nasal Spray. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 18, 2023. The contract is not designated with any set-aside requirements, indicating...
This federal contract award, with the ID SPE2DB22D3004|SPE2DB23FRJ64, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,252,237 units of Naloxone HCl 4 mg Nasal Spray in packages of 2, with a ceiling value of $73,022.74. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 21, 2023. The contract does not have a set-aside...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB23FBTL3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,316,293 units of Naloxone HCl 4 mg Nasal Spray, with an ultimate completion date of September 27, 2023 and a ceiling value of $7,341.79. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM0U3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,563,188,527 units of Naloxone HCl 4 mg Nasal Spray. The contract has a firm fixed price of $2,648.44 and an ultimate completion date of December 28, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
This federal contract award, valued at $1,199.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,071,512 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a completion date of September 7, 2023 and is a firm fixed-price delivery order. There was no set-aside designation for this award, indicating full and open...
This federal contract award is for the delivery of 4,558,909,494 units of Naloxone HCL 4 mg Nasal Spray 2's, procured by the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2022 with a ceiling value of $17,371.69. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,515.16, is for the delivery of 4,567,379,263 units of Naloxone HCL 4 mg Nasal Spray. This is a Firm Fixed Price Delivery Order contract with a completion date of February 26, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime contractor, with no major...
This federal contract award (SPE2DB20D3103|SPE2DB23FP4Q3) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,561,914,420 units of Naloxone HCl 4 mg Nasal Spray. The $4,965.93 firm fixed-price contract has an ultimate completion date of August 24, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...